Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival (2002)
Etienne, P L,
Adenis, A,
Ducreux, M,
Paillot, B,
Oliveira, J,
...
BACKGROUND: Vinorelbine and cisplatin are active against squamous cell oesophageal carcinoma. The purpose of this phase II study was to evaluate the efficacy and safety of vinorelbine plus cisplatin...
Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival (2002)
Conroy, T.,
Adenis, A.,
Ducreux, M.,
Paillot, B.,
Oliveira, J.,
...
Background Vinorelbine and cisplatin are active against squamous cell oesophageal carcinoma. The purpose of this phase II study was to evaluate the efficacy and safety of vinorelbine plus cisplatin...
Modulation of high-dose infusional fluorouracil by low-dose methotrexate in patients with advanced or metastatic colorectal cancer : final results of a randomized European Organization for Research and Treatment of Cancer study (1996)
Sahmoud, T.,
Collette, L.,
Selleslag, J.,
Dalmark, M.,
Lacave, A.J.,
Bleiberg, H.,
...
Multicentre phase II pharmacological evaluation of rhizoxin (1996)
Verweij, J.,
Aamdal, S.,
Wagener, D.J.T.,
Heinrich, B.,
Pavlidis, N.,
...
Phase II trial of Vinorelbine in metastatic squamous cell esophageal carcinoma (1996)
Wils, J.,
Merle, S.,
Delgado, F-M.,
Glabbeke, M. Van,
Pottelsberghe, C. Van,
Bleiberg, H.,
...
Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer : an EORTC GITCCG study (1996)
Wils, J.,
Sahmoud, T.,
Curran, D.,
Conroy, T.,
Graeff, A. De,
Veenhof, C.H.N.,
...
Chimiotherapie premiere par 5-fluoracile, epirubicine, methotrexate a haute dose et cisplatine (FEMTX-P) pour cancer gastrique localement avance (1996)
Wagener, D.J.T.,
Paillot, B.,
Wils, J.,
Magnin, F.,
Guillemin, F.,
Conroy, T.
Fotemustine in patients with advanced gastric cancer, a phase II trial from the EORTC-GITCGG (European Organization for research and treatment of cancer, gastrointestinal tract cancer cooperative group) (1996)
Bleiberg, H.,
Glabbeke, M. Van,
Gerard, B.,
Fabri, M.C.,
Greve, J. De,
Wagener, D.J.T.,
...
Glutathione S-Transferases in gastric carcinomas and in adjacent normal gastric epithelium: Immunohistochemical and biochemical analyses. (1996)
Wagener, D.J.T.,
Verhofstad, A.A.J.,
Wobbes, Th.,
Peters, W.H.M.,
Wagenmans, M.J.M.,
...
Immunohistochemical determination of glutathione S-transferase in gastric carcinomas and in adjacent normal gastric epithelium (1996)
Wagener, D.J.T.,
Lange, W.,
Verhofstad, A.A.J.,
Wobbes, Th.,
Peters, W.H.M.,
...
Phase II trial of CPT-11 in patients with advanced pancreatic cancer, an EORTC early clinical trials group study (1995)
Verweij, J.,
Mathieu-Boue, A.,
Buitenhuis, M.,
Siegenthaler, P.,
Catimel, G.,
Dirix, L.Y.,
...
Short report: Phase II trials of fosquidone (GR63178A) in carcinoma of the breast, head and neck, ovary and melanoma (1992)
Kaye, S. B.,
Wanders, J.,
Clavel, M.,
Verweij, J.,
Piccart, M. J.,
Smyth, J. F.,
...
A total of 91 eligible patients with metastatic cancer have been treated in a series of phase II trials of the novel pentacyclic pyrroloquinone, fosquidone. Tumour types were breast (24), ovary (25),...
Special article: Results of the first ESMO examination in medical oncology, London 1989 (1991)
Alberto, P.,
Mermillod, B.,
Cocconi, P. G.,
Schneider, M.,
Seeber, S.,
Wagener, D. J. T.,
...
Since 1989, a Certification in Medical Oncology is offered to ESMO members on the basis of their professional curriculum vitae and of their scores in a multiple choice examination. The first session...